Guardant Health [GH] vs RadNet [RDNT] Detailed Stock Comparison
Guardant Health
NASDAQ
Loading...
RadNet
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Guardant Health wins in 9 metrics, RadNet wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Guardant Health | RadNet | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -17.45 | 1,425.75 | Guardant Health |
| Price-to-Book Ratio | -25.24 | 6.01 | Guardant Health |
| Debt-to-Equity Ratio | -4.37 | 156.12 | Guardant Health |
| PEG Ratio | 3.66 | -2.48 | RadNet |
| EV/EBITDA | -20.38 | 30.93 | Guardant Health |
| Profit Margin (TTM) | -49.93% | -0.78% | RadNet |
| Operating Margin (TTM) | -45.75% | 7.12% | RadNet |
| EBITDA Margin (TTM) | N/A | 7.12% | N/A |
| Return on Equity | 312.48% | 1.74% | Guardant Health |
| Return on Assets (TTM) | -19.57% | 1.55% | RadNet |
| Free Cash Flow (TTM) | $-274.94M | $44.95M | RadNet |
| 1-Year Return | 177.35% | 14.07% | Guardant Health |
| Price-to-Sales Ratio (TTM) | 9.33 | 3.06 | RadNet |
| Enterprise Value | $8.54B | $7.00B | Guardant Health |
| EV/Revenue Ratio | 10.31 | 3.67 | RadNet |
| Gross Profit Margin (TTM) | 65.01% | 13.88% | Guardant Health |
| Revenue per Share (TTM) | $7 | $26 | RadNet |
| Earnings per Share (Diluted) | $-3.46 | $-0.19 | RadNet |
| Beta (Stock Volatility) | 1.46 | 1.55 | Guardant Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Guardant Health vs RadNet Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Guardant Health | -1.90% | 2.13% | -7.59% | 22.48% | 41.32% | 93.45% |
| RadNet | 0.44% | 4.27% | 11.41% | 40.75% | 49.17% | 11.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Guardant Health | 177.35% | 10.24% | -43.19% | 110.48% | 110.48% | 110.48% |
| RadNet | 14.07% | 312.48% | 363.49% | 1,279.05% | 3,110.25% | 11,090.00% |
News Based Sentiment: Guardant Health vs RadNet
Guardant Health
News based Sentiment: POSITIVE
Guardant Health delivered a strong Q2 performance with revenue exceeding expectations and raised full-year guidance. A significant legal victory and key partnerships further bolster the company's position, though continued cash burn remains a concern. These developments suggest a positive trajectory for the company, making October a significant month for investors.
RadNet
News based Sentiment: MIXED
RadNet demonstrated strong Q2 performance and continued strategic investments in AI and acquisitions, but significant insider selling and a mixed earnings outlook create a complex investment narrative. The combination of positive developments and cautionary signals warrants a 'mixed' sentiment and a relatively high importance score.
Performance & Financial Health Analysis: Guardant Health vs RadNet
| Metric | GH | RDNT |
|---|---|---|
| Market Information | ||
| Market Cap | $7.73B | $5.96B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,782,030 | 718,540 |
| 90 Day Avg. Volume | 2,486,587 | 663,123 |
| Last Close | $61.46 | $78.33 |
| 52 Week Range | $20.14 - $68.00 | $45.00 - $93.65 |
| % from 52W High | -9.62% | -16.36% |
| All-Time High | $181.07 (Feb 08, 2021) | $93.65 (Nov 11, 2024) |
| % from All-Time High | -66.06% | -16.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.08% |
| Quarterly Earnings Growth | 0.31% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.50% | -0.01% |
| Operating Margin (TTM) | -0.46% | 0.07% |
| Return on Equity (TTM) | 3.12% | 0.02% |
| Debt to Equity (MRQ) | -4.37 | 156.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-2.45 | $12.42 |
| Cash per Share (MRQ) | $4.19 | $10.83 |
| Operating Cash Flow (TTM) | $-238,546,000 | $261.76M |
| Levered Free Cash Flow (TTM) | $-131,174,000 | $143.32M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Guardant Health vs RadNet
| Metric | GH | RDNT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -17.45 | 1,425.75 |
| Forward P/E | -22.87 | 99.60 |
| PEG Ratio | 3.66 | -2.48 |
| Price to Sales (TTM) | 9.33 | 3.06 |
| Price to Book (MRQ) | -25.24 | 6.01 |
| Market Capitalization | ||
| Market Capitalization | $7.73B | $5.96B |
| Enterprise Value | $8.54B | $7.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 10.31 | 3.67 |
| Enterprise to EBITDA | -20.38 | 30.93 |
| Risk & Other Metrics | ||
| Beta | 1.46 | 1.55 |
| Book Value per Share (MRQ) | $-2.45 | $12.42 |
Financial Statements Comparison: Guardant Health vs RadNet
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GH | RDNT |
|---|---|---|
| Revenue/Sales | $203.47M | $498.23M |
| Cost of Goods Sold | $74.72M | $429.09M |
| Gross Profit | $128.75M | $69.15M |
| Research & Development | $88.52M | N/A |
| Operating Income (EBIT) | $-111.04M | $33.15M |
| EBITDA | $-83.84M | $81.27M |
| Pre-Tax Income | $-94.87M | $23.85M |
| Income Tax | $290,000 | $820,000 |
| Net Income (Profit) | $-95.16M | $23.03M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GH | RDNT |
|---|---|---|
| Cash & Equivalents | $698.57M | $717.32M |
| Total Current Assets | $927.03M | $1.02B |
| Total Current Liabilities | $225.75M | $505.40M |
| Long-Term Debt | $1.28B | $1.66B |
| Total Shareholders Equity | $-250.79M | $1.14B |
| Retained Earnings | $-2.67B | $-114.71M |
| Property, Plant & Equipment | $140.50M | $1.37B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GH | RDNT |
|---|---|---|
| Operating Cash Flow | $-49.41M | $113.66M |
| Capital Expenditures | $-4.46M | $-52.93M |
| Free Cash Flow | $-67.15M | $67.41M |
| Debt Repayment | N/A | $-7.00M |
| Common Stock Repurchase | $-45.01M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GH | RDNT |
|---|---|---|
| Shares Short | 8.74M | 6.43M |
| Short Ratio | 3.67 | 9.58 |
| Short % of Float | 0.07% | 0.10% |
| Average Daily Volume (10 Day) | 2,782,030 | 718,540 |
| Average Daily Volume (90 Day) | 2,486,587 | 663,123 |
| Shares Outstanding | 123.99M | 74.04M |
| Float Shares | 119.85M | 69.22M |
| % Held by Insiders | 0.04% | 0.13% |
| % Held by Institutions | 0.99% | 0.94% |
Dividend Analysis & Yield Comparison: Guardant Health vs RadNet
| Metric | GH | RDNT |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |